That resource is reserved for health professionals and professionals using DM-DIV

This content is promotional.


The mAbXmise quantification kits are intended to monitor the concentration of therapeutic monoclonal antibodies (mAbs) in samples from patients treated with these mAbs. The kit is a quantitative assay. The test can be performed on plasma (EDTA, heparin or citrate collection tubes) and serum. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product.


This space contains information on medical devices, the use of which is reserved for healthcare professionals. In application of the law of December 29, 2011 relating to the strengthening of health security, I certify that I am a health professional and therefore be authorized to access this information.


mAbXmise monoclonal antibodies quantification kits are In Vitro Diagnostic Medical Devices for laboratory professional use and CE-IVD labeled for Europe by BSI. Assay results are intended to be used by healthcare professionals. The kits are designed to perform absolute quantification by LC-MS (Liquid Chromatography – Mass spectrometry) of specific therapeutic monoclonal antibodies (mAbs) in a patient sample. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product. The products are non-refundable. The mAbXmise Kit described has not been cleared by any regulatory entity for diagnostic purposes outside of Europe. Proteomics mAbXmise Kits are not available for sale in all countries.


I am a healthcare professional


Validate


Close window if you are not a healthcare professional

 

Close menu

Contact

Communication

The first monoclonal antibody monitoring
devices based on mass spectrometry technology
obtain CE-IVDR marking

  • Knowledge about therapeutic antibodies and feedback from clinicians on the use of these drugs highlight a need for optimization. Therapeutic pharmacological monitoring is one of the diagnostic options making it possible to optimize the use of antibodies, for the benefit of patients as a priority.
  • mAbXmise kits are a patented solution combining labeled monoclonal antibodies, reagents and consumables to perform the quantification of monoclonal antibodies by mass spectrometry. This multiplex method has high analytical performances thus offering scientific, clinical and economic perspectives fully meeting the requirements for implementing routine pharmacological monitoring.
  • The range developed and marketed by Promise Proteomics now includes 7 CE-IVD products making it possible to monitor 19 antibodies, which address clinical needs in 6 therapeutic areas, chronic inflammatory diseases, oncology, hematology, transplantation, autoimmune diseases and hemophilia.
DOWNLOAD THE PDF